Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rituxan
Pharma
JPM24: Roche touts its rebound in hematology, led by Hemlibra
After a period of declining sales in hematology, Roche is rebounding quickly with blockbuster Hemlibra and new bispecifics Lunsumio and Columvi.
Kevin Dunleavy
Jan 9, 2024 4:26pm
After pulling Lumoxiti in Europe, AstraZeneca does same in US
Jan 13, 2023 10:15am
Roche pharma CEO Anderson leaves in another leadership shuffle
Dec 12, 2022 9:52am
Bristol's expansion bid for Breyanzi scores FDA priority review
Feb 17, 2022 10:25am
Roche lands approval to slash Gazyvaro infusion time in EU
Oct 19, 2021 7:10am
J&J, Amgen and Roche face growing biosimilar competition
Aug 12, 2021 2:08pm
